 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
| Date |
Open |
High |
Low |
Close |
Volume |
| 09/08/2026 |
$350.49 |
$354.69 |
$343.46 |
$351.26 |
255.80K | | 09/09/2026 |
$348.85 |
$353.12 |
$340.18 |
$348.09 |
222.30K | | 09/10/2026 |
$347.56 |
$349.65 |
$344.26 |
$345.55 |
175.80K | | 09/11/2026 |
$349.59 |
$354.24 |
$346.68 |
$347.00 |
206.30K | | 09/14/2026 |
$349.14 |
$352.55 |
$339.25 |
$340.03 |
288.50K |
 |
| Krystal Biotech, Inc. is an integrated, commercial-stage biotechnology company. It is focused on the discovery, development, and commercialization of genetic medicines to treat diseases with high unmet medical needs. Its product candidates in various stages of clinical and preclinical development include VYJUVEK, KB407, KB408, KB707, KB105, KB104, KB104, and KB301. Its commercial product VYJUVEK is a non-invasive, topical, redo sable gene therapy designed to deliver two copies of theCOL7A1 gene when applied directly to DEB wounds. | |
 |

Krystal Biotech (KRYS) has the following price history information. Looking back at KRYS historical stock prices for the last five trading days, on September 08, 2026, KRYS opened at $350.49, traded as high as $354.69 and as low as $343.46, and closed at $351.26. Trading volume was a total of 255.80K shares. On September 09, 2026, KRYS opened at $348.85, traded as high as $353.12 and as low as $340.18, and closed at $348.09. Trading volume was a total of 222.30K shares. On September 10, 2026, KRYS opened at $347.56, traded as high as $349.65 and as low as $344.26, and closed at $345.55. Trading volume was a total of 175.80K shares. On September 11, 2026, KRYS opened at $349.59, traded as high as $354.24 and as low as $346.68, and closed at $347.00. Trading volume was a total of 206.30K shares. On September 14, 2026, KRYS opened at $349.14, traded as high as $352.55 and as low as $339.25, and closed at $340.03. Trading volume was a total of 288.50K shares.
KRYS Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Krystal Biotech shares, starting with a $10,000 purchase of KRYS, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
09/21/2017 |
|
| End date: |
09/14/2026 |
|
| Start price/share: |
$10.25 |
|
| End price/share: |
$340.03 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
3,217.37% |
|
| Average Annual Total Return: |
47.65% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$331,728.51 |
|
| Years: |
8.99 |
|
|
 |
| Date |
Close |
| 09/08/2026 | $351.26 | | 09/09/2026 | $348.09 | | 09/10/2026 | $345.55 | | 09/11/2026 | $347.00 | | 09/14/2026 | $340.03 |
|
 |